Related Experiment Video
Updated: Mar 3, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Predictive Variables for Abnormal Comprehensive Metabolic Panel Testing and Potential Cost Savings in Children
Matthew David Huckaby1, Shayla Freeman, Christopher Thurmond
1From the *Louisiana State University Health Science Center Shreveport, Shreveport, LA; and †Medical University of South Carolina, Charleston, SC.
In pediatric emergency departments, a basic metabolic panel (BMP) may suffice for patients without specific clinical indicators, potentially saving costs. This approach avoids unnecessary comprehensive metabolic panels (CMP).
Area of Science:
- Pediatric Emergency Medicine
- Clinical Chemistry
- Health Economics
Background:
- Comprehensive metabolic panels (CMP) are frequently ordered in pediatric emergency departments (PEDs).
- Identifying which pediatric patients truly require a CMP versus a basic metabolic panel (BMP) is crucial for optimizing resource utilization and cost-effectiveness.
Purpose of the Study:
- To identify clinical variables that predict abnormal liver function test (LFT) results in pediatric patients.
- To evaluate the potential cost savings of utilizing a BMP instead of a CMP when specific clinical indicators are absent.
Main Methods:
- A retrospective cross-sectional descriptive study was conducted on 207 children (<18 years) in an urban academic PED.
- Twelve clinical variables and liver function test (LFT) results were analyzed to identify predictors of abnormal CMP results.
Main Results:
- History of liver disease, history of heart disease, jaundice, and hepatomegaly were significantly associated with abnormal LFT results (P < 0.05).
- A false-negative rate of 16% was observed for LFTs, with marginally abnormal values in most cases.
- Ordering only a BMP for patients lacking the 12 clinical variables could result in an estimated annual cost saving of $7125.
Conclusions:
- A BMP may be adequate for pediatric patients in the PED who present without specific clinical variables suggestive of liver dysfunction.
- Implementing a strategy to limit CMP testing to higher-risk patients could lead to significant cost savings in the pediatric emergency setting.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution